Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case
An Israel-based pharmaceutical company
has agreed to an $85 million settlement with the state of Oklahoma over its alleged role in fueling the opioid crisis.
Oklahoma Attorney General Mike Hunter
had accused Teva Pharmaceuticals of creating a public nuisance through its production and marketing of opioids.
In a statement announcing the settlement,
Teva said the agreement “does not establish any wrongdoing on the part of the company.” Teva also said it “has not contributed to the abuse of opioids in Oklahoma in any way.”
The settlement makes Teva the second company to settle with Oklahoma over the opioid epidemic. In March,
Purdue Pharma, the maker of OxyContin, agreed to a $270 million settlement with the state.
Teva, the world’s largest generic drugmaker, had been due to appear in court on Tuesday alongside Johnson & Johnson.
NPR